Xilio Therapeutics, Inc. announced that Dave Gardner of Rock Springs Capital and Andrew Hack, M.D., Ph.D, of Bain Capital Life Sciences will join the Xilio Therapeutics Board of Directors.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.958 USD | +1.17% |
|
-9.50% | +72.76% |
Jun. 13 | Xilio Therapeutics, Inc. Announces Board Appointments | CI |
May. 14 | Xilio Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+72.76% | 34.95M | |
+34.14% | 51.07B | |
-8.05% | 38.78B | |
+35.88% | 38.61B | |
-10.62% | 27.32B | |
+12.10% | 26.35B | |
-19.13% | 19.46B | |
+41.33% | 13.58B | |
+29.30% | 12.46B | |
-4.06% | 11.75B |
- Stock Market
- Equities
- XLO Stock
- News Xilio Therapeutics, Inc.
- Xilioxilio Therapeutics, Inc. Announces Executive Changes